FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB4 days ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Federal Trade Commission sues largest drug middlemen for ... - CNN
WEB4 days ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
FTC sues pharmacy benefit managers for inflating price of insulin : …
WEB3 days ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
Federal Trade Commission accuses three drug middlemen of …
WEB4 days ago · The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices. The FTC accused the "Big Three" pharmacy benefit managers (PBMs ...
FTC sues drug 'gatekeepers' over high insulin prices - USA TODAY
WEB4 days ago · 0:04. 1:12. The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin to reap ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs. The interim staff report, which is part of an ongoing inquiry launched in 2022 by the FTC, details how ...
Federal Trade Commission to sue drug middlemen over prices of ...
WEBJul 10, 2024 · The FTC on Tuesday released a scathing interim report based on the ongoing investigation into PBMs. The report accused the three largest PBMs of manipulating the drug supply chain to enrich...
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
FTC sues PBMs, affiliated GPOs for inflating insulin prices
WEB1 day ago · FTC sues PBMs, affiliated GPOs for inflating insulin prices. Caremark Rx, Express Scripts, and OptumRx are facing legal repercussions after the FTC accused them of insulin price inflation in a lawsuit announced on Sept. 20, 2024. Caremark Rx, Express Scripts, Optum Rx and their affiliated group purchasing organizations are being accused by …
Skip to content